A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA's Bioastronautics Roadmap (2006)

Chapter: Appendix B Methods

Visit NAP.edu/10766 to get more information about this book, to buy it in print, or to download it as a free PDF.
Previous Chapter: Appendix A Bibliography of Related National Academies Reports
Page 89 Cite Bookmark
Suggested Citation: "Appendix B Methods." Institute of Medicine and National Research Council. 2006. A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA's Bioastronautics Roadmap. Washington, DC: The National Academies Press. doi: 10.17226/11467.
Save
Cancel

B
Methods

The committee developed this interim report and arrived at conclusions and recommendations regarding the strengths and weaknesses of the Bioastronautics Roadmap (BR) during a 13-month period from April 2004 to May 2005. During this time, the committee held four data-gathering sessions; made one site visit to the Johnson Space Center in Houston, Texas; and met in closed session seven times to deliberate. Agendas for the open, data-gathering sessions of these meetings are included in this appendix.

Page 90 Cite Bookmark
Suggested Citation: "Appendix B Methods." Institute of Medicine and National Research Council. 2006. A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA's Bioastronautics Roadmap. Washington, DC: The National Academies Press. doi: 10.17226/11467.
Save
Cancel

INSTITUTE OF MEDICINE

AGENDA

Committee on Aerospace Medicine and Medicine in Extreme Environments

and

Committee on Review of NASA’s Bioastronautics

Critical Path Roadmap

Keck Building

500 5th Street, NW

Washington, DC

Room 110

Monday, April 12, 2004

CLOSED SESSION

(committee and staff only)

8:00 a.m.–12:00 p.m.

OPEN SESSION

12:00 p.m.

Lunch

1:00 p.m.

Request for a review of the Bioastronautics Critical Path Roadmap (BCPR)

Richard Williams, M.D., Chief Health and Medical Officer, NASA

1:10 p.m.

Overview of the Bioastronautics Critical Path Roadmap

NASA presenters: Guy Fogleman, director of bioastronautics research, Office of Biological and Physical Research; Howard Ross, acting deputy associate administrator for science, Office of Biological and Physical Research; Marc Shepanek, deputy chief, Medicine of Extreme Environments, NASA; Frank Sulzman, manager, Space Radiation Health Project

1:20 p.m.

How the Bioastronautics Critical Path Roadmap captures the critical risks and key research and technology issues for risk reduction, management, and informed decision making
Page 91 Cite Bookmark
Suggested Citation: "Appendix B Methods." Institute of Medicine and National Research Council. 2006. A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA's Bioastronautics Roadmap. Washington, DC: The National Academies Press. doi: 10.17226/11467.
Save
Cancel

1:40 p.m.

The Bioastronautics Critical Path Roadmap’s method and expression of risk assessment for medical decision making and the BCPR communication of these methods for different mission scenarios

2:20 p.m.

Types of risks and impacts of risk as expressed in the Bioastronautics Critical Path Roadmap

3:00 p.m.

Break

3:30 p.m.

Categories of critical research issues and metrics used in the Bioastronautics Critical Path Roadmap

4:10 p.m.

Efficiency and technology issues in the Bioastronautics Critical Path Roadmap

4:50 p.m.

Plenary discussion

Led by David Longnecker, M.D.

5:30 p.m.

Adjourn to reception and dinner with invited guests

Location: third floor atrium

Tuesday, April 13, 2004

OPEN SESSION

8:00 a.m.

Continental breakfast

8:30 a.m.

Welcoming remarks

David Longnecker, M.D.

8:45 a.m.

Overview of related work by the National Academies

9:00 a.m.

Space Studies Board/ASEB

9:30 a.m.

CAMMEE

10:00 a.m.

Break

CLOSED SESSION

(committee and staff only)

10:15 a.m.–3:30 p.m.

Page 92 Cite Bookmark
Suggested Citation: "Appendix B Methods." Institute of Medicine and National Research Council. 2006. A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA's Bioastronautics Roadmap. Washington, DC: The National Academies Press. doi: 10.17226/11467.
Save
Cancel

INSTITUTE OF MEDICINE

AGENDA

Committee on Review of NASA’s Bioastronautics

Critical Path Roadmap

Keck Building

500 5th Street, NW

Washington, DC

Room 204

Wednesday, June 9, 2004

OPEN SESSION

9:00 a.m.

Welcome and overview of day’s agenda

David Longnecker, M.D., and Lisa Vandemark, Ph.D.

9:15 a.m.

Briefings related to the review of the Bioastronautics Critical Path Roadmap

NASA presenters: Lauren Leveton, Bioastronautics Science Management Team, NASA; Holly Patton, Aerospace Technologist, NASA; David Tomko, Lead Scientist, Biomedical Program, BASA Bioastronautics Research Division; Guy Fogleman, Director of Bioastronautics Research, Office of Biological and Physical Research; Frank Sulzman, Manager, Space Radiation Health Project

12:00 p.m.

Lunch

1:00 p.m.

Bone loss and countermeasures: historical perspectives and new in-flight clinical studies

Jay Shapiro, M.D., Uniformed Services University of the Health Sciences

2:00 p.m.

Harmonization of crew living module and extravehicular pressure suit atmospheric constituents and pressures

Bruce McCandless, M.S., M.B.A., Lockheed Martin

3:00 p.m.

Break

3:30 p.m.

An overview of space biology from cells to humans

David Klaus, Ph.D., University of Colorado, Boulder

4:30 p.m.

Plenary discussion

Led by David Longnecker, M.D.

5:30 p.m.

Adjourn
Page 93 Cite Bookmark
Suggested Citation: "Appendix B Methods." Institute of Medicine and National Research Council. 2006. A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA's Bioastronautics Roadmap. Washington, DC: The National Academies Press. doi: 10.17226/11467.
Save
Cancel

Thursday, June 10, 2004

CLOSED SESSION

(committee and staff only)

8:30 a.m.–3:00 p.m.

INSTITUTE OF MEDICINE

AGENDA

Committee on Review of NASA’s Bioastronautics

Critical Path Roadmap

Keck Building

500 5th Street, NW

Washington, DC

Room 201

Monday, August 2, 2004

OPEN SESSION

9:00 a.m.

Welcome, introductions, and overview of day’s agenda

David Longnecker, M.D., and Lisa Vandemark, Ph.D.

9:20 a.m.

Briefings related to the review of the Bioastronautics Critical Path Roadmap

Richard Williams, M.D.

10:30 a.m.

Break

11:00 a.m.

Briefings related to the review of the Bioastronautics Critical Path Roadmap

NASA presenters via videoconference from Johnson Space Center: Guy Fogleman, Director of Bioastronautics Research, Office of Biological and Physical Research; Marc Shepanek, Deputy Chief, Medicine of Extreme Environments, NASA; Desmond Lugg, Chief, Medicine of Extreme Environments, Office of the Chief Medical Officer

11:30 a.m.

Question-and-answer discussion

David Longnecker, M.D., Moderator

12:00 p.m.

Lunch
Page 94 Cite Bookmark
Suggested Citation: "Appendix B Methods." Institute of Medicine and National Research Council. 2006. A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA's Bioastronautics Roadmap. Washington, DC: The National Academies Press. doi: 10.17226/11467.
Save
Cancel

1:00 p.m.

Advanced life support issues

Brian Dunaway, Boeing Corporation

CLOSED SESSION

(committee and staff only)

2:30 p.m.–5:30 p.m.

Tuesday, August 3, 2004

CLOSED SESSION

(committee and staff only)

8:30 a.m.–3:00 p.m.

INSTITUTE OF MEDICINE

AGENDA

Committee on Review of NASA’s Bioastronautics

Critical Path Roadmap

National Academy of Sciences Building

2101 Constitution Avenue, NW

Washington, DC

Lecture Room

Monday, January 31, 2005

OPEN SESSION

9:00 a.m.

Welcome and introductions

David E. Longnecker, M.D., Chair

9:20 a.m.

Overview of the day’s agenda

Lisa M. Vandemark, Ph.D., Study Director

9:30 a.m.

Guest presentations

Admiral Walter Cantrell, NASA Headquarters; Joseph Genovese, Hamilton Sunstrand; Joseph Fuller, Futron Corporation

12:00 p.m.

Lunch
Page 95 Cite Bookmark
Suggested Citation: "Appendix B Methods." Institute of Medicine and National Research Council. 2006. A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA's Bioastronautics Roadmap. Washington, DC: The National Academies Press. doi: 10.17226/11467.
Save
Cancel

1:00 p.m.

Guest presentations

Geoffrey McIntyre, Federal Aviation Administration; Michael Gernhardt, NASA Johnson Space Center; Alan Feiveson, NASA Johnson Space Center (via phone conference); William Stone, Stone Aerospace

3:15 p.m.

Break

4:00 p.m.

Overview of the new Bioastronautics Roadmap

Lauren Leveton, Ph.D., NASA Headquarters

4:30 p.m.

Plenary discussion

Led by David Longnecker, M.D.

5:30 p.m.

Adjourn

Tuesday, February 1, 2005

CLOSED SESSION

(committee and staff only)

Page 96 Cite Bookmark
Suggested Citation: "Appendix B Methods." Institute of Medicine and National Research Council. 2006. A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA's Bioastronautics Roadmap. Washington, DC: The National Academies Press. doi: 10.17226/11467.
Save
Cancel

This page intentionally left blank.

Page 89 Cite Bookmark
Suggested Citation: "Appendix B Methods." Institute of Medicine and National Research Council. 2006. A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA's Bioastronautics Roadmap. Washington, DC: The National Academies Press. doi: 10.17226/11467.
Save
Cancel
Page 89
Page 90 Cite Bookmark
Suggested Citation: "Appendix B Methods." Institute of Medicine and National Research Council. 2006. A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA's Bioastronautics Roadmap. Washington, DC: The National Academies Press. doi: 10.17226/11467.
Save
Cancel
Page 90
Page 91 Cite Bookmark
Suggested Citation: "Appendix B Methods." Institute of Medicine and National Research Council. 2006. A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA's Bioastronautics Roadmap. Washington, DC: The National Academies Press. doi: 10.17226/11467.
Save
Cancel
Page 91
Page 92 Cite Bookmark
Suggested Citation: "Appendix B Methods." Institute of Medicine and National Research Council. 2006. A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA's Bioastronautics Roadmap. Washington, DC: The National Academies Press. doi: 10.17226/11467.
Save
Cancel
Page 92
Page 93 Cite Bookmark
Suggested Citation: "Appendix B Methods." Institute of Medicine and National Research Council. 2006. A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA's Bioastronautics Roadmap. Washington, DC: The National Academies Press. doi: 10.17226/11467.
Save
Cancel
Page 93
Page 94 Cite Bookmark
Suggested Citation: "Appendix B Methods." Institute of Medicine and National Research Council. 2006. A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA's Bioastronautics Roadmap. Washington, DC: The National Academies Press. doi: 10.17226/11467.
Save
Cancel
Page 94
Page 95 Cite Bookmark
Suggested Citation: "Appendix B Methods." Institute of Medicine and National Research Council. 2006. A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA's Bioastronautics Roadmap. Washington, DC: The National Academies Press. doi: 10.17226/11467.
Save
Cancel
Page 95
Page 96 Cite Bookmark
Suggested Citation: "Appendix B Methods." Institute of Medicine and National Research Council. 2006. A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA's Bioastronautics Roadmap. Washington, DC: The National Academies Press. doi: 10.17226/11467.
Save
Cancel
Page 96
Next Chapter: Appendix C Status of Countermeasure and Technology Readiness Levels
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.